These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1430999)

  • 21. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia.
    Belliveau P; Hickingbotham N; Maderazo EG; Mazens-Sullivan M; Robinson A
    Pharmacotherapy; 1993; 13(4):396-401. PubMed ID: 8361868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pefloxacin therapy for nosocomial infections in the intensive care unit.
    Potgieter PD
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():83-9. PubMed ID: 2258356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases.
    Fang GD; Fine M; Orloff J; Arisumi D; Yu VL; Kapoor W; Grayston JT; Wang SP; Kohler R; Muder RR
    Medicine (Baltimore); 1990 Sep; 69(5):307-16. PubMed ID: 2205784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
    Wallace RJ; Niefield SL; Waters S; Waters B; Awe RJ; Wiss K; Martin RR; Greenberg SB
    Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital.
    Greenaway CA; Embil J; Orr PH; McLeod J; Dyck B; Nicolle LE
    Infect Control Hosp Epidemiol; 1997 Nov; 18(11):749-56. PubMed ID: 9397368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.
    Schleupner CJ; Engle JC
    Antimicrob Agents Chemother; 1982 Feb; 21(2):327-33. PubMed ID: 6280600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical pharmacy-oriented drug surveillance network: results of a nationwide antibiotic utilization review of bacterial pneumonia--1987.
    Grasela TH; Schentag JJ; Boekenoogen SJ; Crist KD; Lowes WL; Lum BL
    DICP; 1989 Feb; 23(2):162-70. PubMed ID: 2728507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic antibiotic treatment of nosocomial pneumonia.
    Unertl KE; Lenhart FP; Forst H; Peter K
    Intensive Care Med; 1992; 18 Suppl 1():S28-34. PubMed ID: 1640030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology, and treatment.
    Bentley DW
    Gerontology; 1984; 30(5):297-307. PubMed ID: 6386609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceforanide (BL-S786) in the treatment of community-acquired bacterial pneumonia.
    Wallace RJ; Martin RR; Greenberg SB
    Infection; 1979; 7(4):176-9. PubMed ID: 315929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of pneumonia: unexpected incidence of legionellosis.
    Rudin JE; Wing EJ
    South Med J; 1986 Apr; 79(4):417-9. PubMed ID: 3486480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
    Bhadade R; Harde M; deSouza R; More A; Bharmal R
    Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nosocomial pneumonia. Diagnostic and therapeutic considerations.
    Cunha BA
    Med Clin North Am; 2001 Jan; 85(1):79-114. PubMed ID: 11190353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nosocomial pneumonia: pathogenesis and recent advances in diagnosis and therapy.
    Scheld WM; Mandell GL
    Rev Infect Dis; 1991; 13 Suppl 9():S743-51. PubMed ID: 1925319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial pneumonia in patients in intensive care units.
    Podnos SD; Toews GB; Pierce AK
    West J Med; 1985 Nov; 143(5):622-7. PubMed ID: 3909641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute bacterial meningitis in adults. A review of 493 episodes.
    Durand ML; Calderwood SB; Weber DJ; Miller SI; Southwick FS; Caviness VS; Swartz MN
    N Engl J Med; 1993 Jan; 328(1):21-8. PubMed ID: 8416268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antimicrobial resistance pattern of nosocomial and community bacterial pathogens at a teaching hospital in Tehran,Iran.
    Zamani S; Nasiri MJ; Khoshgnab BN; Ashrafi A; Abdollahi A
    Acta Med Iran; 2014; 52(3):182-6. PubMed ID: 24901718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.